XENE - Xenon Pharmaceuticals Inc.

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

XENE - Xenon Pharmaceuticals Inc.

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Tue 14'th Aug 2018

PERIOD 2018-05-15 - 2018-08-14
CHANGE -2.15%
PRICE $11.40





Request Prediction

Xenon Pharmaceuticals Inc. Stock Analysis

Technical stock analysis for Tue 14'th Aug 2018

Buy candidate since 2018-07-30 Gain 23.91%
Shorts 0.81% ( 2018-07-31 )
Cash 43.8 mill
Loans n/a
Beta 0.69
ROA -44.07

Xenon Pharmaceuticals Inc. fell by -2.15% in the last day from $11.65 to $11.40 and has now fallen 4 days in a row. The price has fallen in 6 of the last 10 days , but is still up by 14.57% over the past 2 weeks. Volume has increased in the last day by 16 807 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 121 354 shares bought and sold for approximately $1.38 million.


Xenon Pharmaceuticals Inc. lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 87.23% during the next 3 months and, with 90% probability hold a price between $18.83 and $23.59 at the end of this period.

Click here for today's Top 5 Trending Companies


Xenon Pharmaceuticals Inc. holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $11.05 and $9.90. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Thursday August 09, 2018, which indicates further falls until a new bottom pivot has been found. Xenon Pharmaceuticals Inc. gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 66 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $9.65 and $9.20.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Xenon Pharmaceuticals Inc. finds support just below today's level at $9.65. If this is broken, then the next support from accumulated volume will be at $9.20 and $8.65.

Support: $9.65 Price: $11.40 Resistance: $11.65


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.90 between high and low, or 7.96%. For the last week, the stock has had a daily average volatility of 8.49%.

Our recommended stoploss: $10.76 (-5.58%) (This stock has high daily movements and this gives high risk. There is a sell signal from pivot top found 3 days ago.)

Overall risk:

Very Low Low Medium High Very High


Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.

Buy Candidate

Click for Top 5 Buy Candidates
XENE $11.40 $-0.25(-2.15%)
XENE is down $0.25 today, but where's it headed in September?
Zacks Investment Research is releasing its prediction for XENE based on the 1-3 month system that more than doubles the S&P 500.

Click here – the XENE analysis is free »

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

Proudly made at

in partnership with